Cargando…

NT-pro BNP and plasma-soluble ST2 as promising biomarkers for hypertension, hypertensive heart disease and heart failure in sub-Saharan Africa

Detalles Bibliográficos
Autores principales:	Anastase, Dzudie, Suiru, Dzekem, Andre, Pascal Kengne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Clinics Cardive Publishing 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885052/ https://www.ncbi.nlm.nih.gov/pubmed/29297544

Ejemplares similares

Pulmonary hypertension as seen in a rural area in sub-Saharan Africa: high prevalence, late clinical presentation and a high short-term mortality rate during follow up
por: Anastase, Dzudie, et al.
Publicado: (2018)

Heart failure in sub-Saharan Africa: A literature review with emphasis on individuals with diabetes
por: Kengne, Andre Pascal, et al.
Publicado: (2008)

Prevalent diabetes mellitus in patients with heart failure and disease determinants in sub-Saharan Africans having diabetes with heart failure: a protocol for a systematic review and meta-analysis
por: Aminde, Leopold Ndemnge, et al.
Publicado: (2016)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review
por: Dzudie, Anastase, et al.
Publicado: (2014)

Building and strengthening capacity for cardiovascular research in Africa through technical training workshops: a report of the joint course on health research methods by the Clinical Research Education Networking and Consultancy and the Ivorian Society of Cardiology
por: Dzekem, Bonaventure Suiru, et al.
Publicado: (2017)

NT-proBNP Is a Predictor of Mortality in Adults with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
por: Maurer, Susanne J., et al.
Publicado: (2023)

The Potential Role of Salivary NT-proBNP in Heart Failure
por: Rammos, Aidonis, et al.
Publicado: (2023)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
por: Alawieh, Hussein, et al.
Publicado: (2019)

Using NT-proBNP as a criterion for heart failure hospitalization
por: Tamizifar, Babak, et al.
Publicado: (2012)

The relationship between NT-proBNP and Depression in Patients with Heart Failure
por: Gao, Ying–Hui, et al.
Publicado: (2017)

NT-proBNP and postoperative heart failure in surgery for aortic stenosis
por: Jiang, Huiqi, et al.
Publicado: (2019)

The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
por: Sedlak, Tara L, et al.
Publicado: (2008)

Serum NT-proBNP and TUG1 as novel biomarkers for elderly hypertensive patients with heart failure with preserved ejection fraction
por: Zhang, Shuang, et al.
Publicado: (2021)

A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
por: Linssen, G. C. M., et al.
Publicado: (2018)

Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)

Risk factors for pre‐heart failure or symptomatic heart failure based on NT‐proBNP
por: Aoki, Shoko, et al.
Publicado: (2022)

Association of E/E′ and NT-proBNP with Renal Function in Patients with Essential Hypertension
por: Yang, Yan, et al.
Publicado: (2013)

NT-ProBNP Levels in Saliva and Its Clinical Relevance to Heart Failure
por: Foo, Jared Yong Yang, et al.
Publicado: (2012)

NT-proBNP: A Guide to Improve the Management of Patients with Heart Failure
por: Latini, Roberto, et al.
Publicado: (2014)

NT-proBNP test with improved accuracy for the diagnosis of chronic heart failure
por: Pan, Yesheng, et al.
Publicado: (2017)

NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure
por: Komarnicki, Paweł, et al.
Publicado: (2023)

Illuminating the pathway for the next generation of cardiovascular medicine practitioners and researchers: Highlights of the Joint PASCAR–SCC clinical symposium on hypertension and heart failure, Cameroon
por: Abanda, Martin H, et al.
Publicado: (2017)

Soluble neprilysin, NT-proBNP, and growth differentiation factor-15 as biomarkers for heart failure in dialysis patients (SONGBIRD)
por: Claus, Robert, et al.
Publicado: (2020)

The Effect of Amlodipine and Sildenafil on the NT-ProBNP Level of Patients with COPD-Induced Pulmonary Hypertension
por: Sharif-kashani, Babak, et al.
Publicado: (2014)

Usefulness of NT-proBNP in dogs with heartworm: could this biomarker be useful to evaluate pulmonary hypertension?
por: Costa-Rodríguez, Noelia, et al.
Publicado: (2023)

Sensitivity and specificity of NT-proBNP to detect heart failure at post mortem examination
por: Sabatasso, Sara, et al.
Publicado: (2011)

Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients
por: Cabré, Anna, et al.
Publicado: (2013)

Inflammatory markers and incident heart failure in older men: the role of NT-proBNP
por: McKechnie, Douglas GJ, et al.
Publicado: (2021)

NT‐proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure
por: Schmitt, Walter, et al.
Publicado: (2021)

Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry
por: Wolodimeroff, Elena, et al.
Publicado: (2022)

Prognostic value of RDW alone and in combination with NT‐proBNP in patients with heart failure
por: Liang, Lin, et al.
Publicado: (2022)

NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme
por: Sweeney, Claire, et al.
Publicado: (2021)

Prevalence, predictors and adverse outcomes of adolescent pregnancy in sub-Saharan Africa: a protocol of a systematic review
por: Sama, Carlson-Babila, et al.
Publicado: (2017)

Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions
por: Pan, Wei, et al.
Publicado: (2020)

Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)

Electrocardiogram, Echocardiogram and NT-proBNP in Screening for Thromboembolism Pulmonary Hypertension in Patients after Pulmonary Embolism
por: Dzikowska-Diduch, Olga, et al.
Publicado: (2022)

Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room?
por: Ozturk, Tuba Cimilli, et al.
Publicado: (2011)

Heart rhythm turbulence and NT-proBNP in decompensated liver cirrhosis – a pilot study
por: Poliwczak, Adam Rafał, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9k29kvdetatq9nm97jhebnrjlg